Assenagon Asset Management Portfolio holdings
AUM
$63B
1-Year Return
16.23%
This Quarter Return
+2.68%
1 Year Return
+16.23%
3 Year Return
+96.75%
5 Year Return
+146.12%
10 Year Return
–
AUM
$55.7B
AUM Growth
+$7.26B
(+15%)
Cap. Flow
+$6.83B
Cap. Flow
% of AUM
12.25%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
1,435
New
117
Increased
473
Reduced
672
Closed
150
Top Buys
| 1 |
Microsoft
MSFT
|
$1.93B |
| 2 |
Tesla
TSLA
|
$1.46B |
| 3 |
Texas Instruments
TXN
|
$813M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$553M |
| 5 |
ConocoPhillips
COP
|
$351M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.16B |
| 2 |
NVIDIA
NVDA
|
$531M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$401M |
| 4 |
Netflix
NFLX
|
$313M |
| 5 |
Meta Platforms (Facebook)
META
|
$309M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Consumer Discretionary | 17.39% |
| 3 | Financials | 11.38% |
| 4 | Healthcare | 11.2% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Restaurant Brands International
QSR
$20.4B
| $219K | ﹤0.01% |
3,358
-19,217
| -85% | -$1.25M |
|
1252
Brookfield Asset Management
BAM
$95.2B
| $215K | ﹤0.01% |
+3,958
| New | +$215K |
|
1253
Denny's
DENN
$248M
| $203K | ﹤0.01% |
33,587
| – | – |
|
1254
Azenta
AZTA
$1.35B
| $200K | ﹤0.01% |
+4,003
| New | +$200K |
|
1255
Tejon Ranch
TRC
$456M
| $192K | ﹤0.01% |
12,099
-2,762
| -19% | -$43.9K |
|
1256
Vipshop
VIPS
$8.37B
| $191K | ﹤0.01% |
14,153
-8,325
| -37% | -$112K |
|
1257
Identive
INVE
$89M
| $189K | ﹤0.01% |
51,711
-116,714
| -69% | -$427K |
|
1258
Host Hotels & Resorts
HST
$12.1B
| $188K | ﹤0.01% |
10,738
-1,573
| -13% | -$27.6K |
|
1259
FibroGen
FGEN
$45.7M
| $186K | ﹤0.01% |
14,074
-16,633
| -54% | -$220K |
|
1260
Forrester Research
FORR
$185M
| $173K | ﹤0.01% |
11,019
-649
| -6% | -$10.2K |
|
1261
XP
XP
$9.43B
| $170K | ﹤0.01% |
14,324
-1,607
| -10% | -$19K |
|
1262
TripAdvisor
TRIP
$2.09B
| $163K | ﹤0.01% |
11,007
-761,585
| -99% | -$11.2M |
|
1263
Telus
TU
$25B
| $156K | ﹤0.01% |
11,520
| – | – |
|
1264
Harvard Bioscience
HBIO
$20.8M
| $147K | ﹤0.01% |
69,799
-132,516
| -65% | -$280K |
|
1265
Crawford & Co Class A
CRD.A
$546M
| $139K | ﹤0.01% |
12,022
-1,740
| -13% | -$20.1K |
|
|
QVCGA
1266
QVC Group, Inc. Series A Common Stock
QVCGA
$79.4M
| $134K | ﹤0.01% |
8,149
-25,150
| -76% | -$415K |
|
1267
Capitol Federal Financial
CFFN
$853M
| $131K | ﹤0.01% |
22,162
-549,849
| -96% | -$3.25M |
|
1268
Clearside Biomedical
CLSD
$27.5M
| $125K | ﹤0.01% |
131,913
-125,190
| -49% | -$119K |
|
1269
Alphatec Holdings
ATEC
$2.45B
| $115K | ﹤0.01% |
12,526
-27,960
| -69% | -$257K |
|
1270
BioCryst Pharmaceuticals
BCRX
$1.74B
| $106K | ﹤0.01% |
14,071
| – | – |
|
1271
Titan International
TWI
$560M
| $92.5K | ﹤0.01% |
13,622
-154,557
| -92% | -$1.05M |
|
1272
Commercial Vehicle Group
CVGI
$61.8M
| $90.8K | ﹤0.01% |
36,625
-199,942
| -85% | -$496K |
|
1273
Vera Bradley
VRA
$60.9M
| $78K | ﹤0.01% |
19,845
-179
| -0.9% | -$703 |
|
1274
LivePerson
LPSN
$86.3M
| $68K | ﹤0.01% |
+44,732
| New | +$68K |
|
1275
Ovid Therapeutics
OVID
$91.7M
| $65.5K | ﹤0.01% |
70,114
-16,175
| -19% | -$15.1K |
|